Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986122 · ClinicalTrials.gov registry record · NA

Virtual Contexts for Affective Modulation

A NA study of Anxiety and Memory, sponsored by Trustees of Dartmouth College.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06986122: Recruiting NA study of Anxiety and Memory, sponsored by Trustees of Dartmouth College.

NCT06986122 is a NA study of Anxiety and Memory that is actively recruiting participants, run by Trustees of Dartmouth College. The registered enrollment target is 20 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986122, a NA study of Anxiety and Memory, is actively recruiting participants, sponsored by Trustees of Dartmouth College.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study investigates how spatial context and perceived controllability modulate pain, affective states such as anxiety, and motivated behavior. The study examines how control over pain and threat-related environments influences pain perception, state anxiety, associated autonomic responses, and behavior. The main questions it aims to answer are: Does having control over pain within specific contexts alter how much pain people feel-even when the stimulus intensity remains constant? How do different types of environments (safe, controllable, or uncontrollable) shape pain-related brain activity, subjective anxiety, and physiological arousal? How do people perform cognitively demanding or distracting tasks (and retain their memory) when under threat versus when in control? Lastly, how do these learned associations with spatial contexts persist or adapt when environmental contingencies are explicitly changed? Taken together, exploration of these factors may lay the groundwork for understanding how placebo-related mechanisms-including perceived control, contextual learning, emotional engagement, and distraction-interact to shape pain and anxiety in complex environments.

Primary Outcome

Self-reported pain level following each thermal stimulus, measured on a visual analog scale. 0-100 scale with 0 indicating no pain and higher values indicating more pain.

Interventions

  • BEHAVIORAL Pain Threat Manipulation
  • BEHAVIORAL Pain Controllability Manipulation

Study Locations (1)

New Hampshire

  • Dartmouth College - Hanover

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-10-28
Est. Completion 2029-06-15
Phase NA
Trustees of Dartmouth College

31 total trials

What NCT06986122 shows while recruiting

NCT06986122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Pain Threat Manipulation is the first listed.

NCT06986122 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06986122 about?

NCT06986122 is a clinical study titled "Virtual Contexts for Affective Modulation". This study investigates how spatial context and perceived controllability modulate pain, affective states such as anxiety, and motivated behavior. The study examines how control over pain and threat-related environments influences pain perception, state anxiety, associated autonomic responses, and b...

What is the current status of trial NCT06986122?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-28. Estimated completion is 2029-06-15.

What conditions does trial NCT06986122 study?

This clinical trial studies the following conditions: Anxiety, Memory, Pain Control.

What interventions are being tested in trial NCT06986122?

The interventions under investigation include: Pain Threat Manipulation (BEHAVIORAL), Pain Controllability Manipulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06986122?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986122 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06986122's enrollment target sits among peer trials

20 326th of 364 higher than 34 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06986122, the US trial registry maintained by the National Library of Medicine. NCT06986122 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.